Stay updated on Nivolumab in Metastatic Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Bladder Cancer Clinical Trial page
- ChecktodayChange DetectedA new Revision: v3.5.4 label was added to the page, and the previous Revision: v3.5.3 label was removed. This reflects a deployment or version update rather than changes to the study content or user-facing information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag changed to Revision: v3.5.3, replacing Revision: v3.5.2, indicating a metadata/update version for the study record. This appears to be a minor update to the page's revision history rather than content changes.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe site revision label was updated from Revision: v3.5.0 to Revision: v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedUpdated the Italy location entry from Napoli, Italy, 80131 to Naples, Italy, 80131 and updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in Metastatic Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.